Interruption of selective serotonin reuptake inhibitor treatment

2000179 citationsJournal Articlebronze Open Access

Authors

David Michelson · Eli Lilly (United States)

Maurizio Fava · Massachusetts General Hospital

Jay D. Amsterdam · Philadelphia University

Jeffrey Apter

Peter D. Londborg · Seattle Institute for Biomedical and Clinical Research

Roy Tamura · Eli Lilly (United States)

R. Tepner · Eli Lilly (United States)

Abstract

Abrupt interruption of SSRI treatment can result in a syndrome characterised by specific physical and psychological symptoms. Incidence, timing and severity of symptoms vary among SSRIs in a fashion that appears to be related to plasma elimination characteristics.

Topics & Keywords

Treatment of Major Depression Electroconvulsive Therapy Studies Schizophrenia research and treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The British Journal of Psychiatry

Volume 176, Issue 4, pp. 363-368

DOI: 10.1192/bjp.176.4.363

Field-Weighted Citation Impact: 7.70